PAR
Click for more information
12.7% 31.0¢ paradigm biopharmaceuticals limited..

Worst Case Consideration, page-23

  1. Denial
    9,704 Posts.
    lightbulb Created with Sketch. 1234
    clock Created with Sketch.
    15/02/23
    09:01
    Post #: 66252871
    It's simple than that

    Pain will be the main driver for patients to seek help
    and doctors will quickly diagnose OA as the culprit. Doctors are very hesitant to now recommend opioids to manage such chronic pain so have very little in their arsenal.
    PAR Price at posting: $1.51 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 5  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
NEWS Buying smarter as baby boomers get boost
right-arrow Created with Sketch.
SKS SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne
right-arrow Created with Sketch.
AUG Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree
right-arrow Created with Sketch.
GED Golden Deeps eyes prospective Cu-Au tenements in NSW with HOA
right-arrow Created with Sketch.
RNU Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
31.0¢ 		Change
0.035(12.7%) 		Mkt cap ! $108.4M
Open High Low Value Volume
27.5¢ 31.0¢ 27.5¢ $108.9K 371.2K

Buyers (Bids)

No. Vol. Price($)
1 1000 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
31.0¢ 17420 5
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.